Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.

Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.

AJNR Am J Neuroradiol. 2016 Jun;37(6):1030-7. doi: 10.3174/ajnr.A4690. Epub 2016 Mar 10.

PMID:
26965463
2.

Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.

Preziosa P, Rocca MA, Pagani E, Stromillo ML, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, Copetti M, De Stefano N, Fazekas F, Bisecco A, Barkhof F, Yousry TA, Arévalo MJ, Filippi M; MAGNIMS Study Group.

Hum Brain Mapp. 2016 Apr;37(4):1627-44. doi: 10.1002/hbm.23125. Epub 2016 Feb 2.

PMID:
26833969
3.

Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.

Tillema JM, Hulst HE, Rocca MA, Vrenken H, Steenwijk MD, Damjanovic D, Enzinger C, Ropele S, Tedeschi G, Gallo A, Ciccarelli O, Rovira A, Montalban X, de Stefano N, Stromillo ML, Filippi M, Barkhof F; MAGNIMS Study Group.

Mult Scler. 2016 Jun;22(7):901-9. doi: 10.1177/1352458515607650. Epub 2015 Oct 2.

PMID:
26432859
4.

Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.

Hulst HE, Schoonheim MM, Van Geest Q, Uitdehaag BM, Barkhof F, Geurts JJ.

Mult Scler. 2015 Nov;21(13):1705-12. doi: 10.1177/1352458514567727. Epub 2015 Feb 13.

PMID:
25680986
5.

Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis.

Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, Barkhof F, Geurts JJ.

Neurology. 2015 Feb 24;84(8):776-83. doi: 10.1212/WNL.0000000000001285. Epub 2015 Jan 23.

6.

Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study.

Rocca MA, Valsasina P, Hulst HE, Abdel-Aziz K, Enzinger C, Gallo A, Pareto D, Riccitelli G, Muhlert N, Ciccarelli O, Barkhof F, Fazekas F, Tedeschi G, Arévalo MJ, Filippi M; MAGNIMS fMRI Study Group.

Hum Brain Mapp. 2014 Dec;35(12):5799-814. doi: 10.1002/hbm.22586. Epub 2014 Jul 18.

PMID:
25045065
7.

Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI?

Hulst HE, Gehring K, Uitdehaag BM, Visser LH, Polman CH, Barkhof F, Sitskoorn MM, Geurts JJ.

Mult Scler. 2014 Jul;20(8):1131-4. doi: 10.1177/1352458513513969. Epub 2013 Nov 25.

PMID:
24277326
8.

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.

Nagtegaal GJ, Pohl C, Wattjes MP, Hulst HE, Freedman MS, Hartung HP, Miller D, Montalban X, Kappos L, Edan G, Pleimes D, Beckman K, Stemper B, Polman CH, Sandbrink R, Barkhof F.

Mult Scler. 2014 Feb;20(2):234-42. doi: 10.1177/1352458513494491. Epub 2013 Jul 10.

PMID:
23842212
9.

Brain atrophy and lesion load predict long term disability in multiple sclerosis.

Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani MP, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, Rovira A, Montalban X, Bodini B, Ciccarelli O, Khaleeli Z, Chard DT, Matthews L, Palace J, Giorgio A, De Stefano N, Eisele P, Gass A, Polman CH, Uitdehaag BM, Messina MJ, Comi G, Filippi M, Barkhof F, Vrenken H; MAGNIMS Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1082-91. doi: 10.1136/jnnp-2012-304094. Epub 2013 Mar 23.

PMID:
23524331
10.

Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions.

Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F.

Neurology. 2013 Mar 12;80(11):1025-32. doi: 10.1212/WNL.0b013e31828726cc. Epub 2013 Mar 6.

PMID:
23468546
11.

Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.

Benedict RH, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B, Geurts JJ, Zivadinov R.

Mult Scler. 2013 Oct;19(11):1478-84. doi: 10.1177/1352458513478675. Epub 2013 Mar 4.

PMID:
23459570
12.

Gray matter imaging in multiple sclerosis: what have we learned?

Hulst HE, Geurts JJ.

BMC Neurol. 2011 Dec 12;11:153. doi: 10.1186/1471-2377-11-153. Review.

13.

Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.

Wiebenga OT, Hulst HE, Kooi EJ, Killestein J, Geurts JJ.

Neurology. 2011 Nov 29;77(22):1998; author reply1999-2000. doi: 10.1212/WNL.0b013e318239c242. No abstract available.

PMID:
22123783
14.

Gender-related differences in functional connectivity in multiple sclerosis.

Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ, Vrenken H, Polman CH, Stam CJ, Barkhof F, Geurts JJ.

Mult Scler. 2012 Feb;18(2):164-73. doi: 10.1177/1352458511422245. Epub 2011 Sep 9.

PMID:
21908484
15.

Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis.

Hulst HE, Schoonheim MM, Roosendaal SD, Popescu V, Schweren LJ, van der Werf YD, Visser LH, Polman CH, Barkhof F, Geurts JJ.

Hum Brain Mapp. 2012 Oct;33(10):2268-80. doi: 10.1002/hbm.21359. Epub 2011 Sep 6.

PMID:
21898674
16.

Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function.

Roosendaal SD, Hulst HE, Vrenken H, Feenstra HE, Castelijns JA, Pouwels PJ, Barkhof F, Geurts JJ.

Radiology. 2010 May;255(2):595-604. doi: 10.1148/radiol.10091433.

PMID:
20413769
17.

Resting state networks change in clinically isolated syndrome.

Roosendaal SD, Schoonheim MM, Hulst HE, Sanz-Arigita EJ, Smith SM, Geurts JJ, Barkhof F.

Brain. 2010 Jun;133(Pt 6):1612-21. doi: 10.1093/brain/awq058. Epub 2010 Mar 30.

18.

Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?

Barkhof F, Hulst HE, Drulovic J, Uitdehaag BM, Matsuda K, Landin R; MN166-001 Investigators.

Neurology. 2010 Mar 30;74(13):1033-40. doi: 10.1212/WNL.0b013e3181d7d651. Epub 2010 Mar 3.

PMID:
20200338
19.

Total brain volume and corpus callosum size in medication-naïve adolescents and young adults with autism spectrum disorder.

Freitag CM, Luders E, Hulst HE, Narr KL, Thompson PM, Toga AW, Krick C, Konrad C.

Biol Psychiatry. 2009 Aug 15;66(4):316-9. doi: 10.1016/j.biopsych.2009.03.011. Epub 2009 May 1.

20.

Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study.

Vellinga MM, Vrenken H, Hulst HE, Polman CH, Uitdehaag BM, Pouwels PJ, Barkhof F, Geurts JJ.

J Magn Reson Imaging. 2009 Apr;29(4):774-9. doi: 10.1002/jmri.21678.

PMID:
19306366
Items per page

Supplemental Content

Loading ...
Write to the Help Desk